Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.598
-0.012 (-1.90%)
At close: Feb 21, 2025, 4:00 PM
0.609
+0.011 (1.77%)
After-hours: Feb 21, 2025, 5:20 PM EST
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $75.54 million as of February 21, 2025. Its market cap has decreased by -60.26% in one year.
Market Cap
75.54M
Enterprise Value
234.85M
1-Year Change
-60.26%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $75.54M, a decrease of -82.94%. That is a compound annual growth rate of -14.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 75.50M | -10.86% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |